Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 316351, 8 pages
http://dx.doi.org/10.1155/2015/316351
Research Article

Mesenchymal Stem Cells Immunosuppressed IL-22 in Patients with Immune Thrombocytopenia via Soluble Cellular Factors

1Department of Hematology, The People’s Hospital of Bozhou, Bozhou 236800, China
2Department of Hematology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou 362000, China

Received 14 April 2015; Revised 12 June 2015; Accepted 14 July 2015

Academic Editor: Menaka C. Thounaojam

Copyright © 2015 Mei Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. da Silva Meirelles, T. T. Sand, R. J. Harman, D. P. Lennon, and A. I. Caplan, “MSC frequency correlates with blood vessel density in equine adipose tissue,” Tissue Engineering Part A, vol. 15, no. 2, pp. 221–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. O. Jang, M. Y. Kim, M. Y. Cho, S. K. Baik, Y. Z. Cho, and S. O. Kwon, “Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model,” BMC Gastroenterology, vol. 14, no. 1, article 198, 2014. View at Publisher · View at Google Scholar
  3. M. A. Antunes, S. C. Abreu, F. F. Cruz et al., “Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema,” Respiratory Research, vol. 15, article 118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. F. P. Barry and J. M. Murphy, “Mesenchymal stem cells. Clinical applications and biological characterization,” International Journal of Biochemistry and Cell Biology, vol. 36, no. 4, pp. 568–584, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. X. Yang, Z.-B. Han, Y. R. Ji et al., “CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties,” PLoS ONE, vol. 8, no. 3, Article ID e59354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Burk, C. Gittel, S. Heller et al., “Gene expression of tendon markers in mesenchymal stromal cells derived from different sources,” BMC Research Notes, vol. 7, article 826, 2014. View at Publisher · View at Google Scholar
  7. L.-L. Lu, Y.-J. Liu, S.-G. Yang et al., “Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials,” Haematologica, vol. 91, no. 8, pp. 1017–1028, 2006. View at Google Scholar · View at Scopus
  8. M. Wu, Z.-B. Han, J. F. Liu et al., “Serum-free media and the immunoregulatory properties of mesenchymal stem cells in vivo and in vitro,” Cellular Physiology and Biochemistry, vol. 33, no. 3, pp. 569–580, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Nevruz, F. Avcu, A. U. Ural et al., “Immunosuppressive effects of multipotent mesenchymal stromal cells on graft-versus-host disease in rats following allogeneic bone marrow transplantation,” Turkish Journal of Hematology, vol. 30, no. 3, pp. 256–262, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. C. Bowles, B. A. Scruggs, and B. A. Bunnell, “Mesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE),” Methods in Molecular Biology, vol. 1213, pp. 303–319, 2014. View at Google Scholar
  11. I. Molendijk, M. Duijvestein, A. E. van der Meulen-de Jong et al., “Immunomodulatory effects of mesenchymal stromal cells in Crohn's disease,” Journal of Allergy, vol. 2012, Article ID 187408, 8 pages, 2012. View at Publisher · View at Google Scholar
  12. R. J. MacFarlane, S. M. Graham, P. S. E. Davies et al., “Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment,” Expert Opinion on Therapeutic Targets, vol. 17, no. 3, pp. 243–254, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. C. D. Thienelt and D. C. Calverley, “Thrombocytopenia caused by immunologic platelet distruction,” in Wintrobe's Clinical Hematology. II, chapter 51, Lippincott Williams & Wilkins, 2009. View at Google Scholar
  14. N.-N. Shan, X.-B. Ji, X. Wang et al., “In vitro recovery of Th1/Th2 balance in PBMCs from patients with immune thrombocytopenia through the actions of IL-18BPa/Fc,” Thrombosis Research, vol. 128, no. 6, pp. e119–e124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Wang, H. Zhao, H. Ren et al., “Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura,” Haematologica, vol. 90, no. 7, pp. 914–923, 2005. View at Google Scholar · View at Scopus
  16. J. Cao, C. Chen, L. Zeng et al., “Elevated plasma IL-22 levels correlated with Th1 and Th22 cells in patients with immune thrombocytopenia,” Clinical Immunology, vol. 141, no. 1, pp. 121–123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Cao, C. Chen, L. Li et al., “Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia,” Journal of Clinical Immunology, vol. 32, no. 3, pp. 523–529, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Hu, H. Li, L. Zhang et al., “Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia,” Human Immunology, vol. 73, no. 6, pp. 629–635, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Glennie, I. Soeiro, P. J. Dyson, E. W.-F. Lam, and F. Dazzi, “Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells,” Blood, vol. 105, no. 7, pp. 2821–2827, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Corcione, F. Benvenuto, E. Ferretti et al., “Human mesenchymal stem cells modulate B-cell functions,” Blood, vol. 107, no. 1, pp. 367–372, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. M. Duffy, T. Ritter, R. Ceredig, and M. D. Griffin, “Mesenchymal stem cell effects on T-cell effector pathways,” Stem Cell Research and Therapy, vol. 2, no. 4, article 34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Chatterjee, N. Marquardt, D. M. Tufa et al., “Role of gamma-secretase in human umbilical-cord derived mesenchymal stem cell mediated suppression of NK cell cytotoxicity,” Cell Communication and Signaling, vol. 12, no. 1, article 63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Dokić, S. Tomić, M. Marković, P. Milosavljević, and M. Čolić, “Mesenchymal stem cells from periapical lesions modulate differentiation and functional properties of monocyte-derived dendritic cells,” European Journal of Immunology, vol. 43, no. 7, pp. 1862–1872, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. X.-X. Jiang, Y. Zhang, B. Liu et al., “Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells,” Blood, vol. 105, no. 10, pp. 4120–4126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Shi, Z.-W. Liu, and F.-S. Wang, “Immunomodulatory properties and therapeutic application of mesenchymal stem cells,” Clinical and Experimental Immunology, vol. 164, no. 1, pp. 1–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Lejeune, L. Dumoutier, S. Constantinescu, W. Kruijer, J. J. Schuringa, and J.-C. Renauld, “Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line: pathways that are shared with and distinct from IL-10,” The Journal of Biological Chemistry, vol. 277, no. 37, pp. 33676–33682, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Liang, J. Wang, H. Chu et al., “Interleukin-22 inhibits bleomycin-induced pulmonary fibrosis,” Mediators of Inflammation, vol. 2013, Article ID 209179, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Nemeth, A. Keane-Myers, J. M. Brown et al., “Bone marrow stromal cells use TGF-β to suppress allergic responses in a mouse model of ragweed-induced asthma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 12, pp. 5652–5657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Chen, D. Wang, W. T. Du et al., “Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism,” Clinical Immunology, vol. 135, no. 3, pp. 448–458, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. C. A. Opitz, U. M. Litzenburger, C. Lutz et al., “Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via Interferon-b and protein kinase R,” Stem Cells, vol. 27, no. 4, pp. 909–919, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. X.-S. Liu, J.-F. Li, S.-S. Wang et al., “Human umbilical cord mesenchymal stem cells infected with adenovirus expressing HGF promote regeneration of damaged neuron cells in a Parkinson's disease model,” BioMed Research International, vol. 2014, Article ID 909657, 7 pages, 2014. View at Publisher · View at Google Scholar
  32. E. Favaro, A. Carpanetto, S. Lamorte et al., “Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes,” Diabetologia, vol. 57, no. 8, pp. 1664–1673, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. W.-H. Liu, J.-J. Liu, J. Wu et al., “Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway,” PLoS ONE, vol. 8, no. 1, Article ID e55487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Selmani, A. Naji, E. Gaiffe et al., “HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells,” Transplantation, vol. 87, no. 9, pp. S62–S66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. T. G. Brock and M. Peters-Golden, “Activation and regulation of cellular eicosanoid biosynthesis,” TheScientificWorldJOURNAL, vol. 7, pp. 1273–1284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. S. L. Tilley, T. M. Coffman, and B. H. Koller, “Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes,” The Journal of Clinical Investigation, vol. 108, no. 1, pp. 15–23, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. R. L. Roper, B. Graf, and R. P. Phipps, “Prostaglandin E2 and cAMP promote B lymphocyte class switching to IgG1,” Immunology Letters, vol. 84, no. 3, pp. 191–198, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. R. Ji, Z. X. Yang, Z.-B. Han et al., “Mesenchymal stem cells support proliferation and terminal differentiation of B cells,” Cellular Physiology and Biochemistry, vol. 30, no. 6, pp. 1526–1537, 2012. View at Publisher · View at Google Scholar · View at Scopus